Harvoni 33.75 mg/150 mg and 45 mg/200 mg coated granules in sachet *

  • Company:

    Gilead Sciences Ltd
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 09 September 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (August 2021)_1631213960.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 6.3 - Shelf life

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 09 September 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (August 2021)_1631213912.pdf

Reasons for updating

  • Change to section 2 - excipient warnings

Updated on 28 July 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI SmPC (July 2021)_1627492859.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 28 July 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules IE & XI PIL (July 2021)_1627492802.pdf

Reasons for updating

  • Change to other sources of information section

Updated on 04 June 2021

File name

Harvoni 33.75 mg-150 mg and 45 mg-200 mg coated granules SmPC (July 2020)_1622820117.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 04 June 2021

File name

Harvoni 33.75 mg - 150 mg and 33.75 mg - 150 mg coated granules IE & XI PIL (May 2021)_1622820017.pdf

Reasons for updating

  • New PIL for new product